1.
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
by Privor-Dumm, Lois A
Vaccine, 2021-08-31, Vol.39 (37), p.5240-5250
2.
Evidence-to-policy gap on hepatitis A vaccine adoption in 6 countries: Literature vs. policymakers’ beliefs
by Ozawa, Sachiko
Vaccine, 2014, Vol.32 (32), p.4089-4096
3.
Cholera control and prevention: Role of evidence-based advocacy and communications
by Nayyar, Anjali
Vaccine, 2020-02-29, Vol.38, p.A178-A180
4.
The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States
by Schoch-Spana, Monica
Vaccine, 2021-09-24, Vol.39 (40), p.6004-6012
5.
Archetype analysis of older adult immunization decision-making and implementation in 34 countries
by Privor-Dumm, Lois
Vaccine, 2020-05-27, Vol.38 (26), p.4170-4182
6.
Words matter: Vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination
by Dudley, Matthew Z
Vaccine, 2020-01-22, Vol.38 (4), p.709-711
7.
Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries
by Sauer, Molly
Vaccine, 2021-03-12, Vol.39 (11), p.1556-1564
8.
One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery
by Haidari, Leila A
Vaccine, 2015, Vol.33 (28), p.3242-3247
9.
Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine
by Bärnighausen, Till
Vaccine, 2010, Vol.29 (13), p.2371-2380
10.
Is the world ready for an Ebola vaccine?
by Lee, Bruce Y
The Lancet (British edition), 2015, Vol.385 (9964), p.203-204
11.
Global use of Haemophilus influenzae type b conjugate vaccine
by Ojo, Linda R
Vaccine, 2010, Vol.28 (43), p.7117-7122
12.
Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenza type b vaccine
by BARNIGHAUSEN, Till
Vaccine, 2011, Vol.29 (13), p.2371-2380
